Reprogramming Macrophages to Increase CD8+ Cell Activation, Taken into Clinical Trials

Time: 9:00 am
day: Conference Day Two

Details:

• Explore mechanisms by which macrophage modulation enhances CD8⁺ T-cell priming and infiltration
• Present preclinical data demonstrating anti-tumor immunity through macrophage reprogramming
• Share translational insights and outcomes from early-phase clinical trials

Speakers:

Shweta Joshi Dr. Joshi leads a research program focused on deciphering how myeloid cells, especially macrophages and MDSCs, drive tumor immunity and how they can be reprogrammed Read more